Study of MDM2 as Prognostic Biomarker in Brain-LGG Cancer and Bioactive Phytochemicals Inhibit the p53-MDM2 Pathway: A Computational Drug Development Approach.

Saved in:
Bibliographic Details
Title: Study of MDM2 as Prognostic Biomarker in Brain-LGG Cancer and Bioactive Phytochemicals Inhibit the p53-MDM2 Pathway: A Computational Drug Development Approach.
Authors: Biswas, Partha1,2,3 (AUTHOR), Bibi, Shabana4,5 (AUTHOR) shabana.bibi.stmu@gmail.com, Yousafi, Qudsia6 (AUTHOR), Mehmood, Asim6 (AUTHOR), Saleem, Shahzad6 (AUTHOR), Ihsan, Awais6 (AUTHOR), Dey, Dipta7 (AUTHOR), Hasan Zilani, Md. Nazmul8 (AUTHOR), Hasan, Md. Nazmul2 (AUTHOR), Saleem, Rasha9 (AUTHOR), Awaji, Aeshah A.10 (AUTHOR), Fahmy, Usama A.11 (AUTHOR) shabana.bibi.stmu@gmail.com, Abdel-Daim, Mohamed M.12,13 (AUTHOR)
Source: Molecules. Apr2023, Vol. 28 Issue 7, p2977. 31p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14203049
DOI:10.3390/molecules28072977